Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We are confident that more broadcasters will soon follow TVNZ's suit."
Got 350,000 @ .003
Rounds me to an even 1,000,000 @ .0039 average.
That should do me for a while. Now sit and wait.
I don't see myself buying Dussault clothing myself, but I'm buying a stock, not clothes. Just can't see myself spending $300+ on a hoodie that I know I'll just get marinara sauce all over!
but Dussault is on a list with Ed Hardy, Affliction and others that will not allow you entrance into any of the downtown core nightclubs. Again, that is the demographic, it's associated with rioters and trouble makers.
Ummm, I have Ed Hardy stuff and my idea of trouble is driving with just one hand on the wheel...
No reason to doubt that!
From Facebook:
Diane says its time to hire an Operations Manager as Epic employees are currently helping Elite! Someone to take charge! Let's get the ball rolling!
Done. Removed Phentermine post. I think we have that covered in a couple of other places.
That's a better approach than speculating!
Thanks!
Unless you work at Elite I don't see how we would know.
Maybe we can speculate a bit?
Chris Dick is listed as the Chief Operating Officer and President of Elite. However his background is not so much operations but business development. Also, looking around LinkedIn I don't see anyone listed there as an Ops Mgr.
Perhaps Chris needs more time to focus on Business Development and wants a good ops person to take on those tasks.
Also, the conversion over to Nevada incorporation neatly saves them about $180,000/year. Enough to hire a good Ops Mgr when taking salary and benefits into consideration.
If a significant individual left Elite wouldn't that be something material requiring a PR?
Thoughts anyone...?
http://www.faqs.org/sec-filings/110919/Dussault-Apparel-Inc_10-Q/R8.htm
Note 3 - Trademark
On April 9, 2010 the Company entered into an asset acquisition agreement with Open Sundaes Ventures Ltd. (“Open Sundaes”) for the acquisition of certain assets relating to the business of the production and development of beauty and bath products including inventory, intellectual property and business knowhow. In consideration for the acquisition of these assets, the Company paid $43,860 and agreed to issue an aggregate of 4,000,002 shares of its common stock to the shareholders of Open Sundaes. The asset acquisition agreement was approved by the shareholders of Open Sundaes at a special meeting held on April 22, 2010. On December 14, 2010, the Company issued a total of 1,026,841 shares pursuant to the asset acquisition agreement. As at the date of these financial statements, the Company has provided the transfer agent with a treasury order to issue the remaining 2,973,161 shares for the acquisition, which would bring the total shares issued pursuant to this agreement, 4,000,002 shares to the shareholders of Open Sundaes and 5,000,000 shares to a creditor of Open Sundaes in settlement of certain debt related to Open Sundaes and agreed to be paid between the parties.
The Company recorded the fair value of Trade Mark based on the fair value of shares issued and cash payments. The total value of the trade mark was $193,239 as of July 31, 2011.
We assess the Trade mark for impairment when events or circumstances indicate that the carrying value may not be recoverable, or, at a minimum, on an annual basis.
Starts at 3am. I finished about 9pm one year
So much for predictions!
I was maybe half right!
Did the ODH (One Day Hike) from DC to Harpers Ferry for the third year in a row. 100k/62 miles in one day. A real test. Really love the area.
Otherwise my hikes are usually in NY/NJ. Typically from 4-14 miles. All a matter of who I'm with!
Have a great weekend all. Going hiking and spa-ing. Be back on Tuesday.
Have a great weekend all. Going hiking and spa-ing. Be back on Tuesday.
No sir. Sorry to confuse. That,s my current position.
I'm at 650k @ .0044
Fingers Crossed
All 500,000 @ .0043 executed
No, limit at .043,only partially filled so far
Ask is slapped @ 500,000 shares.
Have a good morning.
http://www.reuters.com/article/2011/11/15/us-generic-drug-market-idUSTRE7AE2NU20111115
Senate bill to encourage generic drug market
(Reuters) - Generic drugs would have an easier path to U.S. markets under a bill due to be introduced in the Senate, said Democratic Senator Jeff Bingaman, a sponsor of the bill.
The bill also has the support of Republican Senator David Vitter and will be introduced on Wednesday, Bingaman's office said.
It would amend the 1984 Hatch-Waxman Act, which was supposed to empower generic drug companies by allowing them to challenge pharmaceutical patents if they thought they were weak.
If the generic company challenged a drug patent and won, it was rewarded with a 180-day window of exclusivity to sell a generic.
However, one result of that half-year of exclusivity is that brand-name and generic companies will settle a patent lawsuit but sometimes make a deal in which the generic company will stay out of the market for a period of time, according to critics of the practice.
Meanwhile, no other generic may come to market.
In some cases, the brand-name company paid the generic company to delay production, a type of deal the Federal Trade Commission calls "pay for delay."
The Bingaman-Vitter bill would permit any generic company that successfully challenges a drug patent to enter the market, allowing more than one generic company to come to market.
"Everyone who's focused on this set of issues believes that there's a major flaw in the current law, unintended obviously," Bingaman told Reuters. "We think we have a solution to that flaw."
The FTC, which has been fighting the deals, says there were 28 pay-for-delay deals in the 2011 fiscal year that resulted in slower generic entry.
The U.S. agency says the deals violate antitrust law if brand-name pharmaceuticals pay generic drug makers to stay off the market. It has had mixed success before the courts in opposing the deals.
Generic drugs can cost up to 90 percent less than brand-name drugs, although a 20 percent to 30 percent discount is more typical, the agency has said.
Recently, Senators Herb Kohl and Chuck Grassley urged the congressional super committee trying to cut the U.S. budget deficit to ban the pay-for-delay deals.
Kohl has introduced legislation to make the deals illegal and has eight co-sponsors, including Grassley.
Neither bill has a version that has been introduced in the U.S. House of Representatives
I have a feeling....methadone , naltrexone and one other will all come in rapid succession before the end of year.
I have it now.
Does anyone have a comment on this?
$611 ?
Let me shake the piggy bank....
nope
You can listen to the call on a recording but the printed transcript is much nicer to have.
OK, I blew $100 on the last transcript. Who wants to pony up this time?
http://www.alacrastore.com/research/thomson-streetevents-Q2_2012_Elite_Pharmaceuticals_Inc_Earnings_Conference_Call-T4244042
The abuse proof (where theya re to commence commercial batches)is different from the 24 hour. The 24 hour is the one where the effort to get a Euro partner has stalled. Euro partner wants Elite to share in the costs of development. Elite would need $2,000,000 to satisfy that. I don't see that happening any time soon. They didn't say they had a plan B.
I am not certain what the development plan is for the abuse proof.
Maybe someone can jog my memory on that. It might be that they are hopeful for patent approval and with that comes investor interest and capital needed to fund Phase three trials.
It's an important step to prep them for Stage three trials. The samples you use in Stage three trials have to be, I think, from Commercial batches. Someone correct me if I am wrong.
This might help a bit...
Scale-Up and Technology Transfer
http://www.pharmadirections.com/scale-up-tech-transfer
Moving from a clinical to a commercial batch size is seldom as simple as it should be. A formulation that worked well on an 8-station pilot press may fail on a high-speed tablet press. The product that formed a perfect cake in a pilot scale lyophilizer may melt back or collapse when dried in a commercial scale machine. To a novice, it may seem that the unexpected is to be expected when scaling up or transferring a process.
Full scale batches being made of Abuse Proof Oxy.
Need another partner for Oxt 24hr in Europe.
Wonder how much $$ they need?
Said methadone would start shipping later this quarter = December.
No, I don't! :-0
I just want more of this honest back and forth. Its healthy.
I see your point. That royalties is where the growth will be and that manufacturing will be sporadic by its nature.
Maybe my 800k/year projection won't be too far off after 12 months. We'll see!
109k of that 156k was in the first 3 months. So in the last three months we did 47k. From 109k to 47k is not a good trend.
So I see most of the 109k in the first three months as inventory building.
47k in three month = 16k/month.
Will that build? I bet it will.
The initial order is reflected in that which is always high to get shelves stocked.
I looked at the last three months. MUCH lower. What happened?
The initial order is reflected in that which is always high to get shelves stocked.
I looked at the last three months. MUCH lower. What happened?
So if I correct my math...
Phentermine:
So in last three months Elite got 26k in manufacturing revenues plus 21k in royalty revenue or 47k or about 16k per month = $192,000/year.
Not sure where G2 you get 312k but I'll just assume that sales will continue to grow and that 312k will be "the pace" within a few months.
That's still less than half what I assumed initially at 800k.
Admittedly that was MY estimate. But I did ask folks for feedback and I don't remember anyone questioning then.
At the end of the day it looks like a pretty unassuming quarter. Hopefully Lodrane D is at least as much as Phentermine next quarter and we get FDA's/Patents or something.
It seems that the holders of ELTP are all pretty strong. No big selloff today.
Thanks for checking my math!
Phentermine:
From this 10Q:
Elite’s revenue derived from phentermine 37.5mg tablets during the six months ended September 30, 2011 was approximately $308k, with such amount including a $145k milestone payment triggered by the first shipment of the product, $123k in manufacturing revenues and $33k in royalties paid pursuant to the Precision Dose Agreement
From the August 10Q:
Elite’s revenue derived from phentermine 37.5mg tablets during the three months ended June 30, 2011 was approximately $254k, with such amount including a $145k milestone payment triggered by the first shipment of the product, $97k in manufacturing revenues and $12k in royalties paid pursuant to the Precision Dose Agreement.
So in last three months Elite got 26k in manufacturing revenues plus 21k in royalty revenue or 37k or about 12k per month = $144,000/year.
That's very disappointing. Had expected a pace closer to 800k per year.
You think the 10Q would come out today?
Thanks. NJ Army National Guard Tank Company Commander
1986-1993